Your browser doesn't support javascript.
loading
Pharmacokinetics and brain σ1 receptor occupancy of MR309, a selective σ1 receptor antagonist.
Rabiner, Eugenii A; Smith, Kevin; Bennett, Carla; Rizzo, Gaia; Lewis, Yvonne; Mundin, Gill; Dooner, Helen; Oksche, Alexander.
Afiliación
  • Rabiner EA; Invicro(former Imanova Ltd), A Konica Minolta Company, London, UK.
  • Smith K; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
  • Bennett C; Mundipharma Research Limited, Cambridge, UK.
  • Rizzo G; Mundipharma Research Limited, Cambridge, UK.
  • Lewis Y; Invicro(former Imanova Ltd), A Konica Minolta Company, London, UK.
  • Mundin G; Division of Brain Sciences, Department of Medicine, Imperial College, London, UK.
  • Dooner H; Invicro(former Imanova Ltd), A Konica Minolta Company, London, UK.
  • Oksche A; Mundipharma Research Limited, Cambridge, UK.
Br J Clin Pharmacol ; 88(4): 1644-1654, 2022 02.
Article en En | MEDLINE | ID: mdl-34156715

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores sigma / Neuralgia Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores sigma / Neuralgia Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido